Literature DB >> 32914348

The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Hannah E Young1,2, Wendy E Ward3,4.   

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder to affect women in their reproductive years. There has been growing concern that women with PCOS may suffer from long-term metabolic consequences due to the high degree of insulin resistance that is often present in PCOS. However, few longitudinal studies exist in this area and there is a paucity of data on whether women with PCOS are at risk of other chronic diseases as they age. Specifically, current evidence suggests that reproductive-age women with PCOS may be at increased risk for both osteoporosis and periodontal disease (PD)-both these chronic diseases can have serious implications for health and quality of life. However, few studies have addressed how risk factors for osteoporosis and PD may be altered by aging in PCOS. The PCOS phenotype of women beyond reproductive years is poorly understood, and it is not known whether the metabolic profile of older women with PCOS results in an increased risk of osteoporosis and PD. The objective of this review is to discuss the relationships between PCOS, osteoporosis, and PD, and how these relationships could be impacted during aging. The long-term goal of this review is to provide direction for future research that is needed to more clearly elucidate these relationships and eventually provide a basis for evidence-based health recommendations.

Entities:  

Keywords:  Aging; Insulin resistance; Menopause; Osteoporosis; Periodontal disease; Polycystic ovary syndrome

Year:  2020        PMID: 32914348     DOI: 10.1007/s43032-020-00310-7

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  81 in total

Review 1.  How menopause affects oral health, and what we can do about it.

Authors:  Maria Clarinda A Buencamino; Leena Palomo; Holly L Thacker
Journal:  Cleve Clin J Med       Date:  2009-08       Impact factor: 2.321

Review 2.  Association between periodontal disease and polycystic ovary syndrome: a systematic review.

Authors:  S V Kellesarian; V R Malignaggi; T V Kellesarian; A A Al-Kheraif; M M Alwageet; H Malmstrom; G E Romanos; F Javed
Journal:  Int J Impot Res       Date:  2017-03-09       Impact factor: 2.896

3.  Bone mineral density and vitamin D in PCOS and hirsutism.

Authors:  Dorte Glintborg; Anne Pernille Hermann; Marianne Andersen
Journal:  Expert Rev Endocrinol Metab       Date:  2013-09

Review 4.  Metabolic risk in PCOS: phenotype and adiposity impact.

Authors:  Lisa J Moran; Robert J Norman; Helena J Teede
Journal:  Trends Endocrinol Metab       Date:  2015-01-12       Impact factor: 12.015

5.  Periodontal disease in polycystic ovary syndrome.

Authors:  Erhan Dursun; Ferda Alev Akalın; Güliz Nigar Güncü; Nese Çınar; Duygu Yazgan Aksoy; Tolga Fikret Tözüm; Kamer Kılınc; Bülent Okan Yıldız
Journal:  Fertil Steril       Date:  2011-01       Impact factor: 7.329

6.  Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia.

Authors:  Jacqueline A Boyle; Joan Cunningham; Kerin O'Dea; Terry Dunbar; Robert J Norman
Journal:  Med J Aust       Date:  2012-01-16       Impact factor: 7.738

7.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

Review 9.  Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Authors:  Mora Murri; Manuel Luque-Ramírez; María Insenser; Miriam Ojeda-Ojeda; Hector F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-01-09       Impact factor: 15.610

10.  Mortality of women with polycystic ovary syndrome at long-term follow-up.

Authors:  T Pierpoint; P M McKeigue; A J Isaacs; S H Wild; H S Jacobs
Journal:  J Clin Epidemiol       Date:  1998-07       Impact factor: 6.437

View more
  1 in total

1.  Protective effects of liquiritin on polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis via miR-206/PI3K/AKT pathway.

Authors:  Xuan Cui; Shisan Zhou; Yongtao Lin
Journal:  Cytotechnology       Date:  2022-03-21       Impact factor: 2.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.